(3S,4s)-(-)-1-苄基-3,4-二羟基吡咯烷-2,5-二酮 | 187032-53-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: (3S,4s)-(-)-1-苄基-3,4-二羟基吡咯烷-2,5-二酮
• 中文别名: (3S,4S)-1-苄基-3,4-二羟基吡咯烷-2,5-酮
• 英文名称: (3S,4S)-1-benzyl-3,4-dihydroxypyrrolidine-2,5-dione
• CAS: 187032-53-7
• 化学式: C₁₁H₁₁NO₄
• 分子量: 221.213
• InChiKey: IZBMPGFJNIDMRR-IUCAKERBSA-N

物化性质

• 熔点：
  194-197 °C(Solv: ethanol (64-17-5))
• 沸点：
  489.3±45.0 °C(Predicted)
• 密度：
  1.525±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.5
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  77.8
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (3S,4s)-(-)-1-苄基-3,4-二羟基吡咯烷-2,5-二酮 在 硼烷四氢呋喃络合物 作用下， 以 四氢呋喃 为溶剂， 反应 3.0h， 以86.59%的产率得到(3S,4S)-1-苄基吡咯烷-3,4-二醇
  参考文献：
  名称：

  Synthesis and α-glucosidase inhibition activity of dihydroxy pyrrolidines

  摘要：

  A new series of Deacetylsarmentamide A and B derivatives, amides and sulfonamides of 3,4-dihydroxypyrrolidines as alpha-glucosidase inhibitors were designed and synthesized. The biological screening test against alpha-glucosidase showed that some of these compounds have the positive inhibitory activity against alpha-glucosidase. Saturated aliphatic amides were more potent than the olefinic amides. Among all the compounds, 5o/6o having polar -NH2 group, 10f/11f having polar -OH group on phenyl ring displayed 3-4-fold more potent than the standard drugs. Acarbose, Voglibose and Miglitol were used as standard references. The promising compounds 6i, 5o, 6o, 10a, 11a, 10f and 11f have been identified. Molecular docking simulations were done for compounds to identify important binding modes responsible for inhibition activity of alpha-glucosidase. (C) 2017 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2017.04.078
• 作为产物：
  描述：

  苄胺 、 酒石酸 在 丙酮 、 乙醇 作用下， 以 邻二甲苯 为溶剂， 以to afford the product (120 g, 77%)的产率得到(3S,4s)-(-)-1-苄基-3,4-二羟基吡咯烷-2,5-二酮
  参考文献：
  名称：

  Substituted 3-Amino-Pyrrolidino-4-Lactams

  摘要：

  该发明提供了式（1）的化合物及其药学上可接受的盐，其中R1，n和R2如本文所述；其组成物；以及其用途。

  公开号：

  US20070299076A1

文献信息

• POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC M2 RECEPTOR
  申请人：Bayer Pharma Aktiengesellschaft

  公开号：US20180297994A1

  公开（公告）日：2018-10-18

  The present application relates to positive allosteric modulators of the muscarinic M2 receptor, especially to novel 7-substituted 1-arylnaphthyridine-3-carboxamides, to processes for preparation thereof, to the use thereof, alone or in combinations, for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, in particular for treatment and/or prevention of cardiovascular disorders and/or renal disorders.

  本申请涉及肌动蛋白M2受体的阳性变构调节剂，特别是新型的7-取代的1-芳基萘啶-3-羧酰胺，以及其制备方法，单独或组合使用于治疗和/或预防疾病，以及用于生产治疗和/或预防疾病的药物，特别是用于治疗和/或预防心血管疾病和/或肾脏疾病。
• Synthesis and biological evaluation of novel 1β-methylcarbapenems having a new moiety at C-2
  作者：Yong Koo Kang、Kye Jung Shin、Kyung Ho Yoo、Kyung Jae Seo、Seung Yong Park、Dong Jin Kim、Sang Woo Park

  DOI：10.1016/s0960-894x(99)00407-2

  日期：1999.8

  The synthesis and biological activity of the novel series of 1 beta-methylcarbapenems 1a-f, bearing a variety of 3",4"-disubstituted pyrrolidinamides as substituents at C-2, are described. Of these carbapenems, diol 1a showed the most potent and well balanced antibacterial activity against Gram-positive and Gram-negative. 1a was also evaluated for pharmacokinetics and in vivo therapeutic efficacy in

  描述了一系列新型的1β-甲基卡巴木烯1a-f的合成和生物活性，这些化合物在C-2处带有多个3“，4”-二取代的吡咯烷基酰胺作为取代基。在这些碳青霉烯类中，二醇1a对革兰氏阳性和革兰氏阴性显示出最有效和最均衡的抗菌活性。还评估了1a在全身感染中的药代动力学和体内治疗功效。
• Exocyclic Deoxyadenosine Adducts of 1,2,3,4-Diepoxybutane: Synthesis, Structural Elucidation, and Mechanistic Studies
  作者：Uthpala Seneviratne、Sergey Antsypovich、Melissa Goggin、Danae Quirk Dorr、Rebecca Guza、Adam Moser、Carrie Thompson、Darrin M. York、Natalia Tretyakova

  DOI：10.1021/tx900312e

  日期：2010.1.18

  guanine within DNA, DEB induces a large number of A → T transversions, suggesting that it forms strongly mispairing lesions at adenine nucleobases. We now report the discovery of three potentially mispairing exocyclic adenine lesions of DEB: N6,N6-(2,3-dihydroxybutan-1,4-diyl)-2′-deoxyadenosine (compound 2), 1,N6-(2-hydroxy-3-hydroxymethylpropan-1,3-diyl)-2′-deoxyadenosine (compound 3), and 1,N6-(1

  1,2,3,4-二环氧丁烷 (DEB) 被认为是 1,3-丁二烯的最终致癌代谢物，1,3-丁二烯是城市空气中存在的一种重要的工业化学品和环境污染物。虽然它优先修饰 DNA 中的鸟嘌呤，但 DEB 会诱导大量 A → T 颠换，表明它在腺嘌呤核碱基处形成强烈的错配损伤。我们现在报告了 DEB 的三个潜在错配环外腺嘌呤病变的发现：N 6 , N 6 -(2,3-dihydroxybutan-1,4-diyl)-2'-deoxyadenosine (compound 2 ), 1, N 6 -( 2-hydroxy-3-hydroxymethylpropan-1,3-diyl)-2'-deoxyadenosine (compound 3 ), and 1, N 6-(1-羟甲基-2-羟基丙烷-1,3-二基)-2'-脱氧腺苷(化合物4 )。新型 DEB-dA 加合物的结构和立体化学由紫外和核磁共振
• Substituted 3-Amino-Pyrrolidino-4-Lactams
  申请人：Piotrowski David W.

  公开号：US20070299076A1

  公开（公告）日：2007-12-27

  The invention provides compounds of formula (1), and the pharmaceutically acceptable salt thereof, wherein R 1 , n and R 2 are as described herein; compositions thereof; and uses thereof.

  这项发明提供了式（1）的化合物，以及其药用可接受的盐，其中R1、n和R2如本文所述；以及它们的组合物；以及它们的用途。
• The Cu-catalyzed asymmetric conjugate addition with chiral diphosphite ligands derived from <scp>D</scp>-(-)-tartaric acid
  作者：Zeng-Bo Pang、Mi Tian、Hai-Feng Li、Lai-Lai Wang

  DOI：10.1080/00397911.2016.1278231

  日期：2017.3.19

  diphosphite ligands, which were derived from D-(-)-tartaric acid, have been synthesized and successfully applied in the Cu-catalyzed asymmetric conjugate addition of organozincs to enones. There was a synergic effect between the stereogenic centers of the D-(-)-tartaric acid skeleton and the axially H8-binaphthyl moieties of ligand 2c. And ligand 2c shows a comparative catalytic performance to ligand 1-N-benzylpyrrolidine-3

  摘要 合成了一系列衍生自 D-(-)-酒石酸的二亚磷酸酯配体，并成功应用于 Cu 催化的有机锌与烯酮的不对称共轭加成。D-(-)-酒石酸骨架的立体中心与配体2c的轴向H8-联萘部分之间存在协同效应。配体 2c 显示了与配体 1-N-benzylpyrrolidine-3,4-bis[(S)-1,1'-H8-binaphthyl-2,2'-diyl]亚磷酸酯-L-酒石酸 1d 的比较催化性能L-(+)-酒石酸。因此，对于环状烯酮，通过简单地选择衍生自 D-(-)-酒石酸或 L-(+)-酒石酸的配体 1d 或 2c，可以以高对映选择性（ee 高达 96%）获得加成产物的两种对映异构体酸。而且，产物的对映体区分意义主要由亚磷酸联萘基团的构型决定。图形概要